At DeviceTalks Minnesota 2018, medtech veteran Michael Pederson provided an inside look at the Abbott-St. Jude Medical merger and what’s ahead for Abbott’s cardiovascular technologies
Pederson tracked his career from a formative stint at HP to his current role as SVP of cardiac arrhythmias and heart failure at Abbott (NYSE:ABT).
To learn more from the brightest minds in medtech, don’t miss DeviceTalks Boston on Oct. 8-10
The post The future of Abbott’s electrophysiology business appeared first on MassDevice.
from MassDevice https://ift.tt/2LDmAPC
Cap comentari:
Publica un comentari a l'entrada